| Due Diligence for Asset Managers |
|---|
|
You have viewed 7 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Glycomimetics Inc | |
|---|---|
| Ticker | CBIO |
| CIK # | 0001253689 |
| CUSIP | G2545C104 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 401 Professional Drive, Suite 250, Gaithersburg, MD 20879 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Glycomimetics Inc | 2009-11-04 | 39.0 M | Exemption: 506 · Remaining: $11,020,588 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001253689] | 10-K | |
| [0001253689] | 10-Q | |
| [0001253689] | 3 | |
| [0001253689] | 4 | |
| [0001253689] | 5 | |
| [0001253689] | 8-K | |
| [0001253689] | SC 13D | |
| [0001253689] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lynch Ryan
Ordinary Shares
|
2025-12-15 | Grant | 8,378 | ||
|
Pinkas Jan
Ordinary Shares
|
2025-12-15 | Grant | 17,507 | ||
|
Doughty Christopher Grant
Ordinary Shares
|
2025-12-15 | Grant | 14,714 | ||
|
Doughty Christopher Grant
Ordinary Shares
|
2025-12-15 | Grant | 8,000 | ||
|
Brumm Joshua T
Ordinary Shares
|
2025-12-15 | Grant | 45,117 | ||
|
Brumm Joshua T
Ordinary Shares
|
2025-12-15 | Grant | 10,000 | ||
|
Scalzo Richard William
Ordinary Shares
|
2025-12-15 | Grant | 14,422 | ||
|
Scalzo Richard William
Ordinary Shares
|
2025-12-15 | Grant | 5,000 | ||
|
McNeill Jonathan
Ordinary Shares
|
2025-12-15 | Grant | 19,507 | ||
|
McNeill Jonathan
Ordinary Shares
|
2025-12-15 | Grant | 6,000 | ||
|
Im Ellie Eunkyung
Ordinary Shares
|
2025-12-15 | Grant | 5,000 | ||
|
Im Ellie Eunkyung
Ordinary Shares
|
2025-12-15 | Grant | 16,298 | ||
|
Lynch Ryan
Ordinary Shares
|
2025-12-15 | Grant | 4,000 | ||
|
Bispham Barbara Harlin
Ordinary Shares
|
2025-12-15 | Grant | 6,000 | ||
|
Bispham Barbara Harlin
Ordinary Shares
|
2025-12-15 | Grant | 12,422 | ||
|
Pinkas Jan
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Grant | 70,025 | $0.00 | |
|
Doughty Christopher Grant
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Grant | 58,855 | $0.00 | |
|
Brumm Joshua T
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Grant | 180,467 | $0.00 | |
|
Scalzo Richard William
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Grant | 57,688 | $0.00 | |
|
McNeill Jonathan
Stock Option (Right to Buy) · derivative
|
2025-12-15 | Grant | 78,029 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 63 | 25,949,547 |
| 2025-12-31 | 58 | 24,103,244 |
| 2025-09-30 | 41 | 11,318,902 |
| 2025-06-30 | 31 | 10,751,780 |
| 2025-03-31 | 1 | 22 |
| 2024-12-31 | 1 | 15 |
| 2023-12-31 | 1 | 66 |
| 2023-09-30 | 33 | 2,166,502 |
| 2023-06-30 | 30 | 2,283,308 |
| 2023-03-31 | 41 | 3,391,980 |
| 2022-12-31 | 37 | 5,030,841 |
| 2022-09-30 | 37 | 7,883,928 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 50,824 | 50,824 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 40 | 40 | Prev | Page 1 | Next |